The latest closing stock price for Neuphoria Therapeutics as of July 22, 2025 is 7.70.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -54.31% compound annual growth rate over 4 years.
The all-time high Neuphoria Therapeutics stock closing price was 176.76 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 12.55, which is 63% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 72.5% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 5.38.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -54.31% compound annual growth rate over 4 years.
The all-time high Neuphoria Therapeutics stock closing price was 176.76 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 12.55, which is 63% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 72.5% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 5.38.